| Primary |
| Product Used For Unknown Indication |
17.6% |
| Spinal Anaesthesia |
16.0% |
| Pre-eclampsia |
12.8% |
| Asthma |
8.0% |
| Eclampsia |
7.2% |
| Convulsion |
4.8% |
| General Anaesthesia |
4.8% |
| Premature Labour |
4.8% |
| Tocolysis |
4.8% |
| Dialysis |
3.2% |
| Hypomagnesaemia |
2.4% |
| Mechanical Ventilation |
2.4% |
| Sedation |
2.4% |
| Blood Magnesium Decreased |
1.6% |
| Constipation |
1.6% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
1.6% |
| Ventricular Tachycardia |
1.6% |
| Analgesic Therapy |
0.8% |
| Bacterial Toxaemia |
0.8% |
| Blood Magnesium Abnormal |
0.8% |
|
| Medication Error |
13.5% |
| Pulmonary Interstitial Emphysema Syndrome |
12.2% |
| Procedural Hypotension |
8.1% |
| Rib Fracture |
8.1% |
| Hypotension |
5.4% |
| Wrong Drug Administered |
5.4% |
| Convulsion |
4.1% |
| Foetal Death |
4.1% |
| Osteopenia |
4.1% |
| Premature Baby |
4.1% |
| Respiratory Disorder Neonatal |
4.1% |
| Unresponsive To Stimuli |
4.1% |
| Urine Output Decreased |
4.1% |
| Bradycardia |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
| Hypermagnesaemia |
2.7% |
| Incorrect Dose Administered |
2.7% |
| Incorrect Drug Administration Rate |
2.7% |
| Infusion Related Reaction |
2.7% |
| Movement Disorder |
2.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.3% |
| Asthma |
13.7% |
| Product Used For Unknown Indication |
11.0% |
| Hypertension |
8.2% |
| Parenteral Nutrition |
7.7% |
| Status Asthmaticus |
3.8% |
| Prophylaxis |
3.5% |
| Pain |
3.4% |
| Drug Exposure During Pregnancy |
2.9% |
| Premedication |
2.9% |
| Rectal Cancer |
2.9% |
| Adverse Drug Reaction |
2.7% |
| Pre-eclampsia |
2.6% |
| Ventricular Tachycardia |
2.5% |
| Colon Cancer |
2.3% |
| Nausea |
2.0% |
| Constipation |
1.9% |
| Drug Therapy |
1.9% |
| Gastrointestinal Disorder |
1.9% |
| Ill-defined Disorder |
1.7% |
|
| Tachycardia Foetal |
12.0% |
| Drug Ineffective |
9.8% |
| Toxic Epidermal Necrolysis |
9.8% |
| Grand Mal Convulsion |
7.5% |
| Premature Baby |
7.5% |
| Oxygen Saturation Decreased |
6.8% |
| Neuromuscular Blockade |
6.0% |
| Tremor |
4.5% |
| Respiratory Failure |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Ventricular Tachycardia |
3.8% |
| Anaphylactic Reaction |
3.0% |
| Completed Suicide |
3.0% |
| Death |
3.0% |
| Hyperhidrosis |
3.0% |
| Medication Error |
3.0% |
| Pulmonary Oedema |
3.0% |
| Cardiac Arrest |
2.3% |
| Creutzfeldt-jakob Disease |
2.3% |
| Disseminated Intravascular Coagulation |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.8% |
| Drug Use For Unknown Indication |
24.9% |
| Prophylaxis |
7.7% |
| Hypertension |
4.3% |
| Pain |
3.7% |
| Nausea |
2.4% |
| Constipation |
2.3% |
| Multiple Myeloma |
1.9% |
| Premedication |
1.9% |
| Adverse Event |
1.4% |
| Depression |
1.3% |
| Colorectal Cancer |
1.3% |
| Insomnia |
1.2% |
| Non-small Cell Lung Cancer |
1.1% |
| Acute Myeloid Leukaemia |
1.1% |
| Coronary Artery Bypass |
1.0% |
| Prophylaxis Of Nausea And Vomiting |
0.9% |
| Diabetes Mellitus |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Asthma |
0.9% |
|
| Vomiting |
13.4% |
| Thrombocytopenia |
6.3% |
| Sepsis |
6.2% |
| Weight Decreased |
6.0% |
| White Blood Cell Count Decreased |
5.7% |
| Pneumonia |
5.4% |
| Pain |
5.2% |
| Weight Increased |
5.1% |
| Renal Failure Acute |
4.9% |
| Renal Failure |
4.4% |
| Pyrexia |
4.3% |
| Death |
4.0% |
| Interstitial Lung Disease |
4.0% |
| Nausea |
4.0% |
| Injury |
3.6% |
| Rash |
3.6% |
| Respiratory Failure |
3.6% |
| Toxic Epidermal Necrolysis |
3.5% |
| Ventricular Septal Defect |
3.5% |
| Fear |
3.4% |
|
| Interacting |
| Hypertension |
15.2% |
| Maternal Exposure During Pregnancy |
15.2% |
| Ill-defined Disorder |
12.1% |
| Local Anaesthesia |
12.1% |
| Pre-eclampsia |
9.1% |
| Anxiety |
7.6% |
| Foetal Exposure During Pregnancy |
7.6% |
| Drug Use For Unknown Indication |
6.1% |
| Product Used For Unknown Indication |
6.1% |
| Chorioretinitis |
3.0% |
| Labour Pain |
3.0% |
| Proteinuria |
3.0% |
|
| Neuromuscular Blockade |
23.5% |
| Tachycardia |
23.5% |
| Drug Interaction |
11.8% |
| Meniscus Operation |
11.8% |
| Unresponsive To Stimuli |
11.8% |
| Apgar Score Low |
5.9% |
| Foetal Heart Rate Abnormal |
5.9% |
| Injection Site Pain |
5.9% |
|
